Your session is about to expire
← Back to Search
REMM-HIIT for Post-COVID-19 Critical Illness (REMMHIIT-COVID Trial)
N/A
Waitlist Available
Led By Paul Wischmeyer, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months post-discharge, 6 months post-hospital discharge
Awards & highlights
Summary
This trial uses technology to remotely monitor and support high-intensity exercise for COVID-19 survivors. The goal is to help these patients rebuild their strength and fitness through short bursts of intense exercise.
Eligible Conditions
- Coronavirus
- Intensive Care Unit
- Fitness Trackers
- High Intensity Interval Training
- Critical Illness
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months post-discharge, 6 months post-hospital discharge
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months post-discharge, 6 months post-hospital discharge
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Change in 6 minute walk test distance from baseline to 3 months after hospital discharge
Change in cognition from 3 months to 6 months after hospital discharge.
Change in cognition from baseline to 3 months after hospital discharge.
+5 moreOther study objectives
Change in biomarkers of aging and resilience, and mitochondrial function from baseline to 3 months post-discharge
Trial Design
2Treatment groups
Experimental Treatment
Group I: REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT)Experimental Treatment1 Intervention
REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT) The intervention consists of high intensity interval training, consisting of a 30-minute exercise session that includes 10 x 1-minute intervals of high intensity 3x/week (e.g., Monday, Wednesday, Friday) and supplemented with 2 sessions per week of strength, balance, and mobility exercises (e.g., Tuesday, Thursday). Exercise will be supported by an activity tracker, which will allow study personnel to track patient heart rates during exercise on a daily basis, allowing them to provide individualized feedback and coaching.
Group II: ComparatorExperimental Treatment1 Intervention
Patients randomized to the control arm will receive the same technology platform and education on exercise options, including HIIT, but will return home to exercise as they see fit without personalized instruction and coaching. They will be remotely monitored, but will not receive feedback unless any adverse events are noted
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT)
2022
N/A
~20
Find a Location
Who is running the clinical trial?
Duke UniversityLead Sponsor
2,424 Previous Clinical Trials
3,066,071 Total Patients Enrolled
Vanderbilt UniversityOTHER
709 Previous Clinical Trials
6,143,695 Total Patients Enrolled
Paul Wischmeyer, MDPrincipal InvestigatorDuke University
6 Previous Clinical Trials
581 Total Patients Enrolled
Media Library
Research Study Groups:
This trial has the following groups:- Group 1: REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT)
- Group 2: Comparator
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger